Kinetics and dynamic evaluation of specific immunotherapy

European Annals of Allergy and Clinical Immunology

Volumn 36, Issue 10, 2004, Pages 375-386

  Pereira, C ^a,b   Botelho, F ^c   Tavares, B ^a,b   Lourenco C ^a   Baeta, C ^a   Palma Carlos, A G ^d   Lima, J ^a   Chieira, C ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF LISBON   (Portugal)

Author keywords

Allergic inflammation; Radio labelled cells; Scintigraphy, 99mTc HMPAO; Specific immunotherapy; Subcutaneous immunotherapy; Sublingual immunotherapy

Indexed keywords

ALLERGEN; BEE VENOM; GRASS POLLEN EXTRACT; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; HOUSE DUST ALLERGEN; HYMENOPTERA VENOM; IMMUNOMODULATING AGENT; LATEX; PLANT EXTRACT;

ADULT; ALLERGIC REACTION; ALLERGIC RHINITIS; ANAPHYLAXIS; AQUEOUS SOLUTION; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; IMMUNOTHERAPY; IN VIVO STUDY; INFLAMMATION; INJECTION SITE REACTION; ISOTOPE LABELING; LEUKOCYTE; LYMPHATIC DRAINAGE; LYMPHOID TISSUE; MALE; PERIPHERAL VEIN; RESPIRATORY TRACT ALLERGY;

ADMINISTRATION, SUBLINGUAL; ADULT; ALLERGENS; ANIMALS; BEE VENOMS; CHEMOTAXIS, LEUKOCYTE; DELAYED-ACTION PREPARATIONS; DESENSITIZATION, IMMUNOLOGIC; ERYTHEMA; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INJECTIONS, SUBCUTANEOUS; INTESTINES; KINETICS; LATEX; LATEX HYPERSENSITIVITY; LEUKOCYTE TRANSFUSION; LYMPHOID TISSUE; MALE; MIDDLE AGED; POLLEN; PYROGLYPHIDAE; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME; TISSUE DISTRIBUTION; WASP VENOMS;

EID: 11144234640     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Bousquet and ARIA Workshop Group. - J Allergy Clin Immunol 2001;108 suppl 5: S147-S336.
2. Bousquet J, Lockey R.-F., Malling H.-J. - WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic disease. Allergy 1998;53 suppl 44: 1-42.
3. Rueff F, Przybilla B, Muller U, Mosbech H. The sting challenge test in Hymenoptera venom allergy. Position paper of the Subcommittee on Insect Venom Allergy of the European Academy of Allergology and Clinical Immunology. Allergy 1996;51:216-25
4. Pereira C., Pedro E., Tavares B. et al. Specific immunotherapy for severe latex allergy. Eur Annals of Allergy Clin Immunol 2003;35:217-25.
5. Akdis C.-A., Blaser K. - Mechanisms of allergen-specific immunotherapy. Allergy 2000;55:522-30.
6. Moller C., Dreborg S., Ferdousi H.-A. et al. - Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol. 2002;109:251-6.
7. Passalacqua G., Canonica G.-W. - Long-lasting clinical efficacy of allergen specific immunotherapy. Allergy 2002;57:275-6.
8. Tella R., Bartra J., San Miguel M. et al. - Effects of specific immunotherapy on the development of new sensitisations in monosensitised patients. Allergol Immunopathol (Madr) 2003;31:221-5.
9. Parmiani S., Fernández-Távora L., Moreno C., Guardia P., Rico P. - Clustered schedules in allergen-specific immunotherapy. Allergol et Immunopathol 2002;30:283-91.
10. García-Sellés J., Pascual A., Funes E., Pagán J.-A., Negro J.-M. - Clinical efficacy of depigmented and glutaraldehyde polymerized therapeutic vaccines of Parietaria judaica. Allergol et Immunopathol 2003;31:63-9.
11. Kagi M.-K., Wuthrich B. - Different methods of local allergen-specific immunotherapy. Allergy 2002;57:379-88.
12. Lleonart R., Moñoz F., Eseverri J.-L. et al. - Inmunoterpai sublingual en nin̄os. Position Paper. Allergol et Immunopathol 2003;31:244-9
13. Passalacqua G., Canonica G.-W. - Sublingual or injection immunotherapy: the final answer? Allergy 2004;59:37-8.
14. Di Rienzo V., Marcucci F., Puccinelli P. et al. - Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mites: a 10-year prospective study. Clin Exp Allergy 2003;33:206-10.
15. Khinchi M.-S., Poulsen L.-K., Carat F., Andre C., Hansen A.-B., Malling H.-J. - Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomised, placebo-controlled, double-blind, double-dummy study. Allergy 2004;59:45-53.
16. Durham S.-R., Till S.-J. - Immunological changes associated with allergen immunotherapy? J Allergy Clin Immunol 1998;102:157-64.
17. Durham S.-R., Ying S., Varney V.-A. et al. - Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases number of cells expressing mesanger RNA for interferon-gamma. J Allergy Clin Immunol 1996;97:1356-65.
18. Hamid Q., Schotman E., Jacobson M., Walker S., Durham S.-R. - Increases in interleukin-12 (IL-12) messenger RNA+ (mRNA+) cells accompany inhibition of allergen induced late skin responses following successful grass pollen immunotherapy. J Allergy Clin Immunol 1997;99:254-60.
19. Ariano R., Merendino R.-A., Minciullo P.-L., Salpietro C.-D., Gangemi S. - Specific immunotherapy effect on interleukin-18 and CD30 serum levels in monosensitized patients with rhinitis. Allergy Asthma Proc 2003;24:179-83.
20. Lewis DB. Allergy immunotherapy and inhibition of Th2 immune responses: a sufficient strategy? Curr Opin Immunol. 2002;14:644-51.
21. Gardner L.-M., O'Hehir R.-E., Rolland J.-M. - High dose allergen stimulation of T cells from house dust mite-allergic subjects induces expansion of IFN-gamma+ T cells, apoptosis of CD4+IL-4+ cells and T cell anergy. Int Arch Allergy Immunol 2004.
22. Pereira C., Paiva A., Todo-Bom A. et al. - Expression of VCAM-1 during allergic reaction in asthmatic patients. Effects of specific immunotherapy. In XVI World Congress of Asthma. Ed HE Neffen, C Baena-Cagnani, A Yañez. Monduzzi Ed, Bologna, Italy; 113-8.
23. Palma Carlos A.-G., Pregal A.-L., Alonso E. et al. - Soluble adhesion molecule levels during immunotherapy for perennial allergic rhinitis and/or asthma. Actma-Asthma 2001;2:116-7.
24. Foussat A., Cottrez F., Brun V., Fournier N., Breittmayer J.-P., Groux H. - A comparative study between T regulatory type 1 and CD4+CD25+ T cells in the control of inflammation. J Immunol 2003;17:5018-26.
25. Akbari O., Stock P., Dekruyff R.-H., Umetsu D.-T. - Role of regulatory T cells in allergy and asthma. Current Opinion in Immunol 2003;15:627-33.
26. Schmit-Weber C.-B., Blaser K. - T-cell tolerance in allergic response. Allergy 2002;57:762-8.
27. Passalacqua G., Albano M., Riccio A. et al. - Clinical and immunological effects of a rush sublingual immunotherapy to Parietaria species: a double-blind, placebo controlled study. J Allergy Clin Immunol 1999;104:964-8.
28. Guez S., Vatrinet C., Fadel R., André C. - House dust-mite sublingual-swallow immunotherapy (SLIT) in perenial rhinitis: a double-blind, placebo-controlled studt. Allergy 2002;55:369-75.
29. Clavel R., Bousquet J., André C. - Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo controlled trial of standardized five-grass pollen extract in rhinitis. Allergy 1998;53:493-8.
30. Ippoliti F., De Santis W., Volterrani A. et al. -Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003;14:216-21.
31. Reich M., Zwacka G., Markert U.-R. - Nonspecific plasma proteins during sublingual immunotherapy. Chem Immunol Allergy 2003;82:99-108.
32. Bagnasco M., Mariani G., Passalacqua G. et al. -Absortion and distribution kinetics of the major Parietaria judaica (Par j 1) administered by noninjectable routes in healthy human beings. J Allergy Clin Immunol 1997;100:122-9.
33. Passalacqua G., Bagnasco M., Mariani G., Falagiani P., Canonica G.-W. - Local immunotherapy: pharmacokinetics and efficacy. Allergy 1998;53:477-84.
34. Peters A.-M., Danpure H.-J., Osman S. et al. - Clinical experience with 99m Tc-hexamethyl propylene-amine oxime for labelling leucocytes and imaging inflammation. Lancet 1986;2:946-9.
35. de Labriolle-Vaylet C.-L., Doloy M.-T., Salat-Trepas M., Petiet A., Colas-Linhart N. - Radiobiology of 99m Tc-labelled lymphocytes. Eur J Nucl Med 1991;18:556.
36. Frier M. - Leucocyte radiolabelling techniques: practical aspects. Scand J Gastroenterol 1994;203 (Suppl): 32-5.
37. Charron M., Di Lorenzo C., Kocoshis S.-A. et al. - (99m)Tc antigranulocyte monoclonal antibody imaging for the detection and assessment of inflammatory bowel disease newly diagnosed by colonoscopy in children. Pediatr Radiol. 2001;31:796-800.
38. Takur M., Seifert C., Madsen M. et al. - Neutrophil labelling: procedures and pitfalls. Semin Nucl Med 1984;14:107-117.
39. International Comission on radiological protection. - Radiation dose to patients from radiopharmaceuticals. ICRp Publication 53, New York. Pergamon Press 1988.
40. Ariano R., Kroon AM, Augeri G., Canonica G.-W., Passalacqua G. - Long-term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized, controlled trial. Allergy 1999;54:313-9.
41. Clot J. Pharmacology of ribosomal immunotherapy. Drugs. 1997;54 (Suppl 1): 33-6.
42. von Bubnoff D., de la Salle H., We_endorf J., Koch S., Hanau D., Bieber T. - Antigen-presenting cells and tolerance induction. Allergy 2002;57:2-8.
43. Novak N., Allam J.-P., Betten H., Haberstok J., Bieber T. -The role of antigen presenting cells at distinct anatomic sites: they accelarate and they slow down allergies. Allergy 2004;59:5-14.
44. Lambrecht B.-N., Hammad H. - Myeloid dendritic cells make it to the top. Clin Exp Allergy 2002;3:805-10.
45. Jonuleit H., Schmitt E. - The regulatory T cell family: distinct subsets and their interrelations. J Immunol 2003;171:6323-7.